Nexalin Technology Inc. Cash Flow Conversion Efficiency
Nexalin Technology Inc. cash flow conversion efficiency. Based on the latest financial reports, Nexalin Technology Inc. (NXL) has a cash flow conversion efficiency ratio of -1.186x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.80 Million) by net assets ($1.52 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nexalin Technology Inc. (2019–2025)
Cash flow conversion efficiency of Nexalin Technology Inc. from 2019 to 2025. This chart illustrates how Nexalin Technology Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Nexalin Technology Inc. for real-time trading data and today's change.
Nexalin Technology Inc. Cash Flow Conversion Ratio Explained
Nexalin Technology Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nexalin Technology Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nexalin Technology Inc. ranked by their cash flow conversion efficiency. Also see NXL market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Magnetite Mines Ltd
AU:MGT
|
-0.030x |
|
MEP Infrastructure Developers Limited
NSE:MEP
|
-0.376x |
|
Kezar Life Sciences Inc
NASDAQ:KZR
|
-0.114x |
|
Inotiv Inc
NASDAQ:NOTV
|
-0.014x |
|
Biomx Inc
NYSE MKT:PHGE
|
-0.685x |
|
Uniinfo Telecom Services Limited
NSE:UNIINFO
|
0.029x |
|
MFC Industrial Real Estate Investment Trust
BK:MIT
|
-25.926x |
|
Baroyeca Gold & Silver Inc
V:BGS
|
0.194x |
Annual Cash Flow Conversion Efficiency for Nexalin Technology Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Nexalin Technology Inc. from 2019 to 2025. Review NXL financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.75 Million | $-4.96 Million | -1.323x | -23.28% |
| 2024-12-31 | $3.68 Million | $-3.94 Million | -1.073x | +10.29% |
| 2023-12-31 | $3.21 Million | $-3.84 Million | -1.196x | -195.75% |
| 2022-12-31 | $5.48 Million | $-2.22 Million | -0.404x | -163.17% |
| 2021-12-31 | $-1.68 Million | $-1.08 Million | 0.640x | +17.91% |
| 2020-12-31 | $-1.59 Million | $-863.47K | 0.543x | -5.60% |
| 2019-12-31 | $-1.18 Million | $-678.34K | 0.575x | -- |
About Nexalin Technology Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 a… Read more